Edgewise Therapeutics EWTX
NASDAQ EWTX
$46.53 -2.21 (-4.53%)
At close: Nov 10, 2026 · 4:00 PM EST

Edgewise Therapeutics (EWTX) Other Non-Current Liabilities (2021 - 2026)

Updated

Edgewise Therapeutics' Other Non-Current Liabilities was $192,000 in Q2 2022, up 2.7% from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2021, Other Non-Current Liabilities at Edgewise Therapeutics came in at $329,000.

  • Quarterly Other Non-Current Liabilities has moved between $187,000 (Q1 2022) and $329,000 (Q4 2021) over five years.
  • Per Business Quant data, EWTX's Other Non-Current Liabilities in the three quarters before Q2 2022 was $187,000 (Q1 2022), $329,000 (Q4 2021) and $295,000 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Edgewise Therapeutics 5.00 Bn 2.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 888,000.00
Jun 30, 2022 192,000.00
Mar 31, 2022 187,000.00
Dec 31, 2021 329,000.00
Sep 30, 2021 295,000.00
API Access

Edgewise Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EWTX&period=max&api_key=YOUR_API_KEY